Cargando…
Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus
Atherosclerotic cardiovascular disease is the major cause of morbidity and mortality in patients with type 1 diabetes mellitus (T1DM). Enhanced platelet reactivity is considered a main determinant of the increased atherothrombotic risk of diabetic patients. Thrombopoietin (THPO), a humoral growth fa...
Autores principales: | Bosco, Ornella, Vizio, Barbara, Gruden, Gabriella, Schiavello, Martina, Lorenzati, Bartolomeo, Cavallo-Perin, Paolo, Russo, Isabella, Montrucchio, Giuseppe, Lupia, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269076/ https://www.ncbi.nlm.nih.gov/pubmed/34210000 http://dx.doi.org/10.3390/ijms22137032 |
Ejemplares similares
-
Thrombopoietin participates in platelet activation in COVID-19 patients
por: Lupia, Enrico, et al.
Publicado: (2022) -
Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: Vizio, Barbara, et al.
Publicado: (2021) -
Thrombopoietin as Biomarker and Mediator of Cardiovascular Damage in Critical Diseases
por: Lupia, Enrico, et al.
Publicado: (2012) -
Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
por: Schiavello, Martina, et al.
Publicado: (2023) -
Platelets and Multi-Organ Failure in Sepsis
por: Greco, Elisabetta, et al.
Publicado: (2017)